Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 1512745, 18 pages
https://doi.org/10.1155/2017/1512745
Research Article

Oxidative Stress Triggered by Apigenin Induces Apoptosis in a Comprehensive Panel of Human Cervical Cancer-Derived Cell Lines

1Postgraduate Program in Bioscience and Physiopathology, Universidade Estadual de Maringá (UEM), Av. Colombo 5790, 87025-210 Maringá, PR, Brazil
2Clinical Cytology and STD Laboratory, Department of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá (UEM), Av. Colombo 5790, 87025-210 Maringá, PR, Brazil
3Postgraduate Program in Pharmaceutical Sciences, Laboratory of Research and Development of Drug Delivery Systems, Universidade Estadual de Maringá (UEM), Av. Colombo 5790, 87025-210 Maringá, PR, Brazil
4Postgraduate Program in Pharmaceutical Science-Clinical Analysis Area, Universidade de São Paulo (USP), Av. Lineu Prestes 580, 05508-900 São Paulo, SP, Brazil

Correspondence should be addressed to Marcia E. L. Consolaro; moc.liamg@oralosnoclem

Received 30 August 2016; Revised 13 December 2016; Accepted 18 December 2016; Published 16 January 2017

Academic Editor: Luciano Saso

Copyright © 2017 Raquel P. Souza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Agency for Research on Cancer (IARC), Globocan 2012: Estimated Incidence, Mortality and Prevalence Worldwide in 2012, International Agency for Research on Cancer, Lyon, France, 2012, http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
  2. W. J. Koh, B. E. Greer, N. R. Abu-Rustum et al., “Uterine sarcoma, version 1.2016: featured updates to the NCCN guidelines,” Journal of the National Comprehensive Cancer Network, vol. 13, no. 11, pp. 1321–1331, 2015. View at Google Scholar
  3. S. K. Kjær, K. Frederiksen, C. Munk, and T. Iftner, “Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence,” Journal of the National Cancer Institute, vol. 102, no. 19, pp. 1478–1488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Schiffman, P. E. Castle, J. Jeronimo, A. C. Rodriguez, and S. Wacholder, “Human papillomavirus and cervical cancer,” Lancet, vol. 370, no. 9590, pp. 890–907, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Li, W. Yuan, B. Zhao et al., “Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma,” Cancer Cell International, vol. 16, article no. 54, 2016. View at Publisher · View at Google Scholar
  6. D. Lorusso, F. Petrelli, A. Coinu, F. Raspagliesi, and S. Barni, “A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer,” Gynecologic Oncology, vol. 133, no. 1, pp. 117–123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Khalil, S. Bellefqih, N. Sahli et al., “Impact of cervical cancer on quality of life: beyond the short term (results from a single institution),” Gynecologic Oncology Research and Practice, vol. 2, article 7, 2015. View at Publisher · View at Google Scholar
  8. G. M. Cragg and D. J. Newman, “Natural products: a continuing source of novel drug leads,” Biochimica et Biophysica Acta - General Subjects, vol. 1830, no. 6, pp. 3670–3695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs from 1981 to 2014,” Journal of Natural Products, vol. 79, no. 3, pp. 629–661, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Kumar and A. K. Pandey, “Chemistry and biological activities of flavonoids: an overview,” The Scientific World Journal, vol. 2013, Article ID 162750, 16 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. H. Yao, Y. M. Jiang, J. Shi et al., “Flavonoids in food and their health benefits,” Plant Foods for Human Nutrition, vol. 59, no. 3, pp. 113–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. F. Birt, S. Hendrich, and W. Wang, “Dietary agents in cancer prevention: flavonoids and isoflavonoids,” Pharmacology and Therapeutics, vol. 90, no. 2-3, pp. 157–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. B. Harborne and C. A. Williams, “Advances in flavonoid research since 1992,” Phytochemistry, vol. 55, no. 6, pp. 481–504, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Patel, S. Shukla, and S. Gupta, “Apigenin and cancer chemoprevention: progress, potential and promise (review),” International Journal of Oncology, vol. 30, no. 1, pp. 233–245, 2007. View at Google Scholar · View at Scopus
  15. W.-Y. Huang, Y.-Z. Cai, and Y. Zhang, “Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention,” Nutrition and Cancer, vol. 62, no. 1, pp. 1–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Lepiniec, I. Debeaujon, J.-M. Routaboul et al., “Genetics and biochemistry of seed flavonoids,” Annual Review of Plant Biology, vol. 57, pp. 405–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Budavari, The Merck Index, Merck & Co, Whitehouse Station, NJ, USA, 13th edition, 1997.
  18. Y.-M. Sun, H.-L. Wu, J.-Y. Wang, Z. Liu, M. Zhai, and R.-Q. Yu, “Simultaneous determination of eight flavonoids in propolis using chemometrics-assisted high performance liquid chromatography-diode array detection,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 962, pp. 59–67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Zhu, J. Wu, S. Li et al., “Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer,” Molecular Medicine Reports, vol. 11, no. 2, pp. 1004–1008, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Czeczot, B. Tudek, J. Kusztelak et al., “Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs,” Mutation Research/Genetic Toxicology, vol. 240, no. 3, pp. 209–216, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Wang, L. Heideman, C. S. Chung, J. C. Pelling, K. J. Koehler, and D. F. Birt, “Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines,” Molecular Carcinogenesis, vol. 28, no. 2, pp. 102–110, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Kobayashi, T. Nakata, and T. Kuzumaki, “Effect of flavonoids on cell cycle progression in prostate cancer cells,” Cancer Letters, vol. 176, no. 1, pp. 17–23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. T.-D. Way, M.-C. Kao, and J.-K. Lin, “Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway,” Journal of Biological Chemistry, vol. 279, no. 6, pp. 4479–4489, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Nabavi, S. Habtemariam, M. Daglia, and S. F. Nabavi, “Apigenin and breast cancers: from chemistry to medicine,” Anti-Cancer Agents in Medicinal Chemistry, vol. 15, no. 6, pp. 728–735, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Das, J. Das, A. Samadder, N. Boujedaini, and A. R. Khuda-Bukhsh, “Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria,” Experimental Biology and Medicine, vol. 237, no. 12, pp. 1433–1448, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. R. G. P. T. Jayasooriya, S.-H. Kang, C.-H. Kang et al., “Apigenin decreases cell viability and telomerase activity in human leukemia cell lines,” Food and Chemical Toxicology, vol. 50, no. 8, pp. 2605–2611, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Maggioni, W. Garavello, R. Rigolio, L. Pignataro, R. Gaini, and G. Nicolini, “Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis,” International Journal of Oncology, vol. 43, no. 5, pp. 1675–1682, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Tong and J. C. Pelling, “Targeting the PI3k/Akt/mTOR axis by apigenin for cancer prevention,” Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 7, pp. 971–978, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. D.-G. Wu, P. Yu, J.-W. Li et al., “Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells,” Toxicology Letters, vol. 224, no. 1, pp. 157–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. Ju, J. G. Kang, J. S. Bae, H. O. Pae, Y. S. Lyu, and B. H. Jeon, “The flavonoid apigenin ameliorates cisplatin-induced nephrotoxicity through reduction of p53 activation and promotion of PI3K/Akt pathway in human renal proximal tubular epithelial cells,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 186436, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Lindenmeyer, H. Li, S. Menashi, C. Soria, and H. Lu, “Apigenin acts on the tumor cell invasion process and regulates protease production,” Nutrition and Cancer, vol. 39, no. 1, pp. 139–147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Shukla, A. Mishra, P. Fu, G. T. MacLennan, M. I. Resnick, and S. Gupta, “Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice,” FASEB Journal, vol. 19, no. 14, pp. 2042–2044, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Shukla, G. T. MacLennan, P. Fu, and S. Gupta, “Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model,” Pharmaceutical Research, vol. 29, no. 6, pp. 1506–1517, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-S. Kim, E. S. Kim, D. Liu et al., “Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer,” Oncotarget, vol. 6, no. 18, pp. 16746–16756, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. L.-Z. Liu, J. Fang, Q. Zhou, X. Hu, X. Shi, and B.-H. Jiang, “Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer,” Molecular Pharmacology, vol. 68, no. 3, pp. 635–643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. K. Buening, J. G. Fortner, R. L. Chang, M.-T. Huang, A. W. Wood, and A. H. Conney, “Activation and inhibition of benzo(a)pyrene and aflatoxin b1 metabolism in human liver microsomes by naturally occurring flavonoids,” Cancer Research, vol. 41, no. 1, pp. 67–72, 1981. View at Google Scholar · View at Scopus
  37. B. Y. Su, H. L. Jung, Y. C. Hae et al., “Inhibitory effects of luteolin isolated from Ixeris sonchifolia hance on the proliferation of HepG2 human hepatocellular carcinoma cells,” Archives of Pharmacal Research, vol. 26, no. 2, pp. 151–156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. P. V. S. Jeyabal, M. B. Syed, M. Venkataraman, J. K. Sambandham, and D. Sakthisekaran, “Apigenin inhibits oxidative stress-induced macromolecular damage in N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinogenesis in Wistar albino rats,” Molecular Carcinogenesis, vol. 44, no. 1, pp. 11–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Llorens, F. A. Miró, A. Casañas et al., “Unbalanced activation of ERK1/2 and MEK1/2 in apigenin-induced HeLa cell death,” Experimental Cell Research, vol. 299, no. 1, pp. 15–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Czyz, Z. Madeja, U. Irmer, W. Korohoda, and D. F. Hülser, “Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro,” International Journal of Cancer, vol. 114, no. 1, pp. 12–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. P.-W. Zheng, L.-C. Chiang, and C.-C. Lin, “Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells,” Life Sciences, vol. 76, no. 12, pp. 1367–1379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Liu, X.-C. Cao, Q. Xiao, and M.-F. Quan, “Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α,” Molecular Medicine Reports, vol. 11, no. 1, pp. 665–669, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Macville, E. Schröck, H. Padilla-Nash et al., “Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping,” Cancer Research, vol. 59, no. 1, pp. 141–150, 1999. View at Google Scholar · View at Scopus
  44. T. C. Wright Jr., L. S. Massad, C. J. Dunton, M. Spitzer, E. J. Wilkinson, and D. Solomon, “2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests,” American Journal of Obstetrics and Gynecology, vol. 197, no. 4, pp. 346–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. H. O. Smith, M. F. Tiffany, C. R. Qualls, and C. R. Key, “The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States—a 24-year population-based study,” Gynecologic Oncology, vol. 78, no. 2, pp. 97–105, 2000. View at Publisher · View at Google Scholar
  46. A. Paloma Vizcaino, V. Moreno, F. Xavier Bosch, N. Muñoz, X. M. Barros-Dios, and D. Maxwell Parkin, “International trends in the incidence of cervical cancer: I. adenocarcinoma and adenosquamous cell carcinomas,” International Journal of Cancer, vol. 75, no. 4, pp. 536–545, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Hernandez-Flores, P. C. Ortiz-Lazareno, J. M. Lerma-Diaz et al., “Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence,” BMC Cancer, vol. 11, article no. 483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Beckenkamp, J. B. Willig, D. B. Santana et al., “Differential expression and enzymatic activity of DPPIV/CD26 affects migration ability of cervical carcinoma cells,” PLoS ONE, vol. 10, no. 7, Article ID e0134305, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Shi, D. Liu, J. Zhang et al., “Extraction and purification of total flavonoids from pine needles of Cedrus deodara contribute to anti-tumor in vitro,” BMC Complementary and Alternative Medicine, vol. 16, article no. 245, 2016. View at Publisher · View at Google Scholar
  50. K. S. Louis and A. C. Siegel, “Cell viability analysis using trypan blue: manual and automated methods,” Methods in Molecular Biology, vol. 740, pp. 7–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. N. A. P. Franken, H. M. Rodermond, J. Stap, J. Haveman, and C. van Bree, “Clonogenic assay of cells in vitro,” Nature Protocols, vol. 1, no. 5, pp. 2315–2319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. R. K. Gary and S. M. Kindell, “Quantitative assay of senescence-associated β-galactosidase activity in mammalian cell extracts,” Analytical Biochemistry, vol. 343, no. 2, pp. 329–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Iqbal, A. Ghildiyal, Sahabjada et al., “Antiproliferative and apoptotic effect of curcumin and TRAIL (TNF related apoptosis inducing ligand) in chronic myeloid leukaemic cells,” Journal of Clinical and Diagnostic Research, vol. 10, no. 4, pp. XC01–XC05, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. E. A. Britta, A. P. Barbosa Silva, T. Ueda-Nakamura et al., “Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis,” PLoS ONE, vol. 7, no. 8, Article ID e41440, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Urani, P. Melchioretto, M. Bruschi, M. Fabbri, M. G. Sacco, and L. Gribaldo, “Impact of cadmium on intracellular zinc levels in HepG2 cells: quantitative evaluations and molecular effects,” BioMed Research International, vol. 2015, Article ID 949514, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. A. K. Shukla, S. Patra, and V. K. Dubey, “Iridoid glucosides from Nyctanthes arbortristis result in increased reactive oxygen species and cellular redox homeostasis imbalance in Leishmania parasite,” European Journal of Medicinal Chemistry, vol. 54, pp. 49–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Xu, Z. Hao, X. Gou et al., “Imaging of reactive oxygen species burst from mitochondria using laser scanning confocal microscopy,” Microscopy Research and Technique, vol. 76, no. 6, pp. 612–617, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Morita, Y. Naito, T. Yoshikawa, and E. Niki, “Plasma lipid oxidation induced by peroxynitrite, hypochlorite, lipoxygenase and peroxyl radicals and its inhibition by antioxidants as assessed by diphenyl-1-pyrenylphosphine,” Redox Biology, vol. 8, pp. 127–135, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Valdameri, M. Trombetta-Lima, P. R. Worfel et al., “Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells,” Chemico-Biological Interactions, vol. 193, no. 2, pp. 180–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. C.-C. Liang, A. Y. Park, and J.-L. Guan, “In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro,” Nature Protocols, vol. 2, no. 2, pp. 329–333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Tomin, R. H. Goldfarb, and P. Albertsson, “In vitro assessment of human natural killer cell migration and invasion,” Methods in Molecular Biology, vol. 1441, pp. 65–74, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Google Scholar · View at Scopus
  63. F. P. Garcia, D. Lazarin-Bidóia, T. Ueda-Nakamura, S. D. O. Silva, and C. V. Nakamura, “Eupomatenoid-5 isolated from leaves of piper regnellii induces apoptosis in leishmania amazonensis,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 940531, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. M. D. C. Avelino-Flores, M. D. C. Cruz-López, F. E. Jiménez-Montejo, and J. Reyes-Leyva, “Cytotoxic activity of the methanolic extract of turnera diffusa willd on breast cancer cells,” Journal of Medicinal Food, vol. 18, no. 3, pp. 299–305, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. H.-J. Noh, E.-G. Sung, J.-Y. Kim, T.-J. Lee, and I.-H. Song, “Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by apigenin via the inhibition of p38 mitogen-activated protein kinase-dependent matrix metalloproteinase-9 expression,” Oncology Reports, vol. 24, no. 1, pp. 277–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Banerjee and M. Mandal, “Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells,” Redox Biology, vol. 5, pp. 153–162, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Gupta, F. Afaq, and H. Mukhtar, “Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells,” Biochemical and Biophysical Research Communications, vol. 287, no. 4, pp. 914–920, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Chakrabarti, H. Patel, J. Price et al., “Carbon nanotubes in cancer therapy including Boron Neutron Capture Therapy (BNCT),” Life Sciences, vol. 16, pp. 403–418, 2012. View at Google Scholar
  69. S. Di Meo, T. T. Reed, P. Venditti, and V. M. Victor, “Role of ROS and RNS sources in physiological and pathological conditions,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1245049, 44 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Sies, “Strategies of antioxidant defense,” European Journal of Biochemistry, vol. 215, no. 2, pp. 213–219, 1993. View at Publisher · View at Google Scholar · View at Scopus
  71. H.-L. Li, D.-D. Chen, X.-H. Li et al., “Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species,” World Journal of Gastroenterology, vol. 8, no. 3, pp. 431–435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. D. A. Ribeiro, D. M. F. Salvadori, and M. E. A. Marques, “Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide,” International Journal of Experimental Pathology, vol. 86, no. 6, pp. 375–381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Pani, O. R. Koch, and T. Galeotti, “The p53-p66shc-Manganese Superoxide Dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 5, pp. 1002–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. H.-F. Lu, Y.-J. Chie, M.-S. Yang et al., “Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathways,” Human and Experimental Toxicology, vol. 30, no. 8, pp. 1053–1061, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. R.-M. Laberge, J. Karwatsky, M. C. Lincoln, M. L. Leimanis, and E. Georges, “Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stress,” Biochemical Pharmacology, vol. 73, no. 11, pp. 1727–1737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Xu, Y. Xin, Y. Diao et al., “Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells,” PLoS ONE, vol. 6, no. 12, Article ID e29169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Horváthová, L. Novotný, D. Tóthová, and A. Vachálková, “Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562,” Neoplasma, vol. 51, no. 5, pp. 395–399, 2004. View at Google Scholar · View at Scopus
  78. W. Lim, S. Park, F. W. Bazer, and G. Song, “Apigenin reduces survival of choriocarcinoma cells by inducing apoptosis via the PI3K/AKT and ERK1/2 MAPK pathways,” Journal of Cellular Physiology, vol. 231, no. 12, pp. 2690–2699, 2016. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Nishikawa, K. Hyoudou, Y. Kobayashi, Y. Umeyama, Y. Takakura, and M. Hashida, “Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes,” Journal of Controlled Release, vol. 109, no. 1–3, pp. 101–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. G. C. Jagetia and T. K. Reddy, “Modulation of radiation-induced alteration in the antioxidant status of mice by naringin,” Life Sciences, vol. 77, no. 7, pp. 780–794, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Szliszka, Z. P. Czuba, M. Domino, B. Mazur, G. Zydowicz, and W. Krol, “Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells,” Molecules, vol. 14, no. 2, pp. 738–754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Chunhua, L. Donglan, F. Xiuqiong et al., “Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT,” Journal of Nutritional Biochemistry, vol. 24, no. 10, pp. 1766–1775, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. G. Agati, E. Azzarello, S. Pollastri, and M. Tattini, “Flavonoids as antioxidants in plants: location and functional significance,” Plant Science, vol. 196, pp. 67–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. Z.-P. Xiao, Z.-Y. Peng, M.-J. Peng, W.-B. Yan, Y.-Z. Ouyang, and H.-L. Zhu, “Flavonoids health benefits and their molecular mechanism,” Mini-Reviews in Medicinal Chemistry, vol. 11, no. 2, pp. 169–177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. C. S. Buer, N. Imin, and M. A. Djordjevic, “Flavonoids: new roles for old molecules,” Journal of Integrative Plant Biology, vol. 52, no. 1, pp. 98–111, 2010. View at Publisher · View at Google Scholar · View at Scopus